Virology group has a long experience in studies evaluating the role of viruses and other microbes in immune-mediated diseases including type 1 diabetes, asthma, allergy and celiac disease. The group has made several publications about microbe-disease associations in prospective cohorts and translated innovations to develop new treatments and better diagnostics.
One major initiative is the project developing an enterovirus vaccine that could prevent severe enterovirus diseases and type 1 diabetes.
The long-term commitment to these research topics has created a strong research center in Tampere with wide international collaboration networks.
